Orphan designation: elebsiran Treatment of hepatitis delta virus infection, 13/12/2024 Positive
Orphan designation: elebsiran Treatment of hepatitis delta virus infection, 13/12/2024 Positive
Orphan designation: elebsiran Treatment of hepatitis delta virus infection, 13/12/2024 Positive
Orphan designation: adeno-associated virus serotype 5 containing the human RORA gene Treatment of inherited retinal dystrophies due to dysfunction in the ABCA4 gene, 13/12/2024 Positive
Orphan designation: diazoxide choline Treatment of glycogen storage disease type I, 13/12/2024 Positive
Veterinary medicines European public assessment report (EPAR): Previcox, firocoxib, Status: Authorised
Human medicines European public assessment report (EPAR): PreHevbri, hepatitis B surface antigen, Date of authorisation: 25/04/2022, Revision: 3, Status: Withdrawn
Veterinary medicines European public assessment report (EPAR): Dany's BienenWohl, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Oxybee, oxalic acid dehydrate, Status: Authorised
Minutes of the CHMP meeting 16-19 September 2024
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2024
Scientific advice and protocol assistance adopted during the CHMP meeting 11-14 November 2024